Viridian Therapeutics, Inc.\DE Payments to Acquire Property, Plant, and Equipment in USD from 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2013 to Q1 2025.
  • Viridian Therapeutics, Inc.\DE Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $86K.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2024 was $511K, a 43.1% decline from 2023.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2023 was $898K, a 12.7% increase from 2022.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2022 was $797K, a 136% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

Viridian Therapeutics, Inc.\DE Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $86K +$86K Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $0 -$115K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $115K -$64K -35.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $179K +$164K +1093% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $15K +$15K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $0 -$37K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $37K -$58K -61.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $95K +$51K +116% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $44K -$61K -58.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $105K +$61K +139% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q1 2015 $44K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16

Viridian Therapeutics, Inc.\DE Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $511K -$387K -43.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 $898K +$101K +12.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $797K +$459K +136% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $338K +$296K +705% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $42K -$42K -50% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $84K -$361K -81.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $445K +$199K +80.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $246K -$4K -1.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $250K +$127K +103% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $123K -$143K -53.8% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 $266K +$261K +5220% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 $5K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.